# Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects

> **NCT05476497** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Allergy Therapeutics** · enrollment: 46 (estimated)

## Conditions studied

- Peanut Allergy

## Interventions

- **BIOLOGICAL:** VLP Peanut
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** VLP Peanut

## Key facts

- **NCT ID:** NCT05476497
- **Lead sponsor:** Allergy Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-10-17
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05476497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05476497, "Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05476497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*